Participants 364 427 7
migraine patients who cannot be adequately helped with triptans
Participants 682 954 7
patients' self-reported historical triptan response (HTR): (1) good HTR (N = 660): response in 75-100% of attacks; (2) intermediate HTR (N = 248): response in 25-74% of attacks; (3) poor HTR/no use (N = 407): response in < 25% of attacks, or patient did not take triptans.
Participants 992 1207 3
the last subgroup comprised mainly (91%) patients who reported that they did not take triptans, but it was not known whether these patients were triptan-naÃ¯ve or had previously used triptans and stopped taking them
